IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$449M
AUM Growth
+$34.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
81
New
Increased
Reduced
Closed

Top Buys

1
+$9.98M
2
+$9.44M
3
+$8.99M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$8.19M
5
AMGN icon
Amgen
AMGN
+$5.95M

Top Sells

1
+$14.9M
2
+$10.3M
3
+$8.71M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$5.03M
5
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$3.67M

Sector Composition

1 Healthcare 97.48%
2 Utilities 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$32.6M 7.26%
144,746
+26,446
2
$23.8M 5.31%
280,000
-9,500
3
$21.7M 4.84%
128,000
+53,000
4
$20.9M 4.66%
285,000
+14,640
5
$20.5M 4.57%
282,784
-120,000
6
$19.3M 4.3%
139,900
-36,500
7
$18.5M 4.13%
126,500
+28,000
8
$17.9M 3.98%
449,000
9
$17.5M 3.89%
113,200
+3,500
10
$17M 3.78%
77,222
11
$14.3M 3.18%
38,550
+10,794
12
$11.8M 2.63%
380,000
13
$11.6M 2.59%
138,100
+35,000
14
$11.4M 2.54%
47,500
+22,000
15
$10.8M 2.41%
355,088
+310,307
16
$10.8M 2.4%
99,873
-138,000
17
$10.1M 2.24%
236,000
18
$9.98M 2.22%
+766,241
19
$9.29M 2.07%
105,156
+50,000
20
$8.68M 1.93%
297,500
21
$8.19M 1.83%
+108,200
22
$7.65M 1.7%
334,500
+211,000
23
$7.64M 1.7%
12,100
+4,400
24
$7.45M 1.66%
74,500
+38,000
25
$5.92M 1.32%
113,456
+34,000
1
2 3 4